Elranatamab

Tagged: 

This topic contains 92 replies, has 14 voices, and was last updated by  sj2909 1 week, 2 days ago.

Viewing 3 posts - 91 through 93 (of 93 total)
  • Author
    Posts
  • #152289

    tmcintyre
    Participant

    Thank you both very much for sharing your experiences. Dave’s reaction is not listed in the info for the drug and seems to have come as a surprise to his consultants.

    We have told them of our worries about continuing with the drug but we’re told to wait for the bmb results.

    Fatigue seems common with most Myeloma treatments, Dave’s has worsened as time goes on but this is the first time in 9 years that he’s had such a bad reaction, previously just skin rashes which eased quite quickly.

    Please keep me updated with your progress, both if you.

    #152370

    lafleck
    Participant

    Hi. I know that it’s early days in the use of Elranatamab but I am aware that some patients have changed from weekly/bi weekly treatments to less frequent treatments, which is contrary to the NICE protocol. I would be very interested to hear how this may have come about ie was this down to you, the patient, requesting the change or at the suggestion of the medical team. Also at what stage this occurred and how it’s all working out for you. Thank you.

    #152371

    sj2909
    Participant

    Hi

    I have just finished my first cycle and started my second. I’ve struggled to be honest, low energy, reactions to the jabs and to the immunoglobulin, let w immunity and blood counts. I spoke to my consultant last Tuesday and she told me that once we get to the end of this second cycle she can review how often I have the jab going forward.

    She told me that they are recognising that it is not necessarily required to give the jab every week to get good results. Once the myeloma is under control it is possible to manage it with less doses with some people going down to once a month. She has said that after this cycle she may be able to move me to everything 2 weeks. I think that usually it is reviewed at 3 months from starting and often reduced at that point if you are having a good response.

    Some time ago I was listening to a radio 4 program about cancer treatment. They had some specialists on the program who were talking about the fact that they are recognising that it is better to treat cancer with less of a sledgehammer approach. Apparently when the cancer is attacked full-on it recognises it and tries to respond. But if it is attacked in a less aggressive way, it doesn’t always recognise that it is being attacked and so this is more effective in treatment. I feel that maybe in lengthening the gaps between the injections it is maybe following this type of approach. It is definitely worth raising all of this I think with your consultant and seeing what they say because as we know everyone is really different in how they respond to treatments. I hope this is helpful and good luck.

Viewing 3 posts - 91 through 93 (of 93 total)

You must be logged in to reply to this topic.